THERAPEUTIC DEVELOPMENT OF NC101 FOR PROMOTING NEUROLOGICAL RECOVERY AFTER CHRONIC SCI

$1,332,764FY2025Defense Health AgencyDOD

Neurocreis, Inc.

Investigators

View source on USAspending →